Literature DB >> 2278857

Estrogen and androgen regulation of sex hormone binding globulin secretion by a human liver cell line.

S E Edmunds1, A P Stubbs, A A Santos, M L Wilkinson.   

Abstract

Both estrogens and androgens have been shown to stimulate sex hormone binding globulin (SHBG) secretion in vitro in the hepatocellular carcinoma cell line, Hep G2, in contrast to the expected inhibition by androgens from in vivo studies. However, such in vitro stimulation was only demonstrated at high steroid doses, generally in serum-containing medium, with added Phenol Red. In the present study, Hep G2 cells were grown in serum-free medium, without Phenol Red, under the influence of testosterone (T) (0, 0.5-500 nM) and ethinyl estradiol (EE2) (0, 50 pM-500 nM). Levels of secreted SHBG and albumin were correlated with androgen receptors in cytosolic (ARc) and nuclear (ARn) fractions and with DNA levels. In the presence of increasing T levels, SHBG levels fell to 39% of control values at 5 nM T (P = 0.047), rising to 97% of control at 500 nM. Conversely, incubation with EE2 produced a rise in SHBG secretion of more than 100% at 0.5 nM (P less than 0.02) which was sustained to 50 nM (P less than 0.005). DNA levels did not change with the addition of testosterone or EE2, with the exception of a 15% reduction at 5 nM EE2 (P less than 0.05). Albumin levels in the medium were not significantly altered by either steroid. However, in response to T, androgen receptor (AR) levels were reduced in cytosolic (42% of control) and nuclear (22%) fractions at 5 nM, and these changes in ARc and ARn correlated with SHBG levels over the range of T concentrations (P = 0.04 and P = 0.017, respectively). Nuclear estrogen receptor (ER) increased over 10-fold at 5 and 50 pM EE2 (P less than 0.001) and maintained 50 nM (P less than 0.001). Cytosolic ER was reduced at 0.5 and 5 nM but recovered at 50 nM, correlating with SHBG levels (P less than 0.001). These findings are consistent with the hypothesis that estrogens and androgens regulate SHBG synthesis in man by direct, specific, probably receptor-mediated effects on hepatocytes. Hep G2 cells grown in serum-free medium are a suitable experimental system for further study of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278857     DOI: 10.1016/0960-0760(90)90358-r

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

1.  Modulatory role of testosterone in plasma leptin turnover in rats.

Authors:  Daniel Castrogiovanni; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

2.  Estrogen responses in killifish (Fundulus heteroclitus) from polluted and unpolluted environments are site- and gene-specific.

Authors:  Sarah R Greytak; Ann M Tarrant; Diane Nacci; Mark E Hahn; Gloria V Callard
Journal:  Aquat Toxicol       Date:  2010-05-19       Impact factor: 4.964

Review 3.  Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery-A Comprehensive Review.

Authors:  Alberto Rosenblatt; Joel Faintuch; Ivan Cecconello
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

Review 4.  Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

Authors:  C Chen; J Smothers; A Lange; J E Nestler; J F Strauss Iii; E P Wickham Iii
Journal:  Minerva Endocrinol       Date:  2010-12       Impact factor: 2.184

5.  Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.

Authors:  Edmond P Wickham; Kathryn G Ewens; Richard S Legro; Andrea Dunaif; John E Nestler; Jerome F Strauss
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

6.  Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, and Asian/Pacific Islander postmenopausal women.

Authors:  Brian H Chen; Kathleen Brennan; Atsushi Goto; Yiqing Song; Najib Aziz; Nai-chieh Y You; Melissa F Wellons; JoAnn E Manson; Donna L White; Anthony W Butch; Simin Liu
Journal:  Clin Chem       Date:  2012-08-20       Impact factor: 8.327

7.  Immunologic and mass-spectrometric estimates of SHBG concentrations in healthy women.

Authors:  Johannes D Veldhuis; Roy B Dyer; Sergey A Trushin; Olga P Bondar; Ravinder J Singh; George G Klee
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

Review 8.  The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

Authors:  Niki Katsiki; Eleni Georgiadou; Apostolos I Hatzitolios
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

9.  Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome.

Authors:  Ricardo Azziz; Wendy Y Chang; Frank Z Stanczyk; Keslie Woods
Journal:  Fertil Steril       Date:  2012-10-31       Impact factor: 7.329

Review 10.  Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.

Authors:  Katerina Harwood; Patricia Vuguin; Joan DiMartino-Nardi
Journal:  Horm Res       Date:  2007-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.